Inventor · disambiguated record
Yu Wang
Also filed as: WANG YU · WANG YU JEAN
7 granted patents·8 pending applications·44 citations·filing 2002–2025
83Inventor score
Files withMABWELL THERAPEUTICS INC5UNIV HONG KONG2COOPER GARTH J1PHILERA NEW ZEALAND LTD1PROTEMIX CORP1
Top patents by PatentIndex Score
15 records- 0189US11866513B2Anti-TMPRSS6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2023·Granted Jan 9, 2024·1 cites·25 claims
- 0284US12215170B2Anti-TMPRSS6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2021·Granted Feb 4, 2025·1 cites·20 claims
- 0383US6884575B2Phosphoprotein target for insulin and its antagonistsPROTEMIX CORP LTD·Filed 2002·Granted Apr 26, 2005·18 cites·16 claims
- 0480US7645616B2Use of lipocalin-2 as a diagnostic marker and therapeutic targetUNIV HONG KONG·Filed 2007·Granted Jan 12, 2010·6 cites·5 claims
- 0579US7365170B2Adiponectin and uses thereofPROTEMIX CORP·Filed 2003·Granted Apr 29, 2008·16 cites·57 claims
- 0676US8044182B2Adiponectin and uses thereofPHILERA NEW ZEALAND LTD·Filed 2008·Granted Oct 25, 2011·2 cites·18 claims
- 0765US2025304719A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0861US2025136718A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0957US2023295345A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1054US8481032B2Lipocalin-2 antibodies for methods of treatmentXU AIMIN·Filed 2009·Granted Jul 9, 2013·0 cites·5 claims
- 1152US2005047998A1Phosphoprotein target for insulin and its antagonistsFiled 2004·Application pending·0 cites
- 1249US2005074756A1FALP proteinsFiled 2003·Application pending·0 cites
- 1347US2007134709A1Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kitXU XIPING·Filed 2006·Application pending·0 cites
- 1446US2007275872A1Peptides with Anti-Obesity Activity and Other Related UsesCOOPER GARTH J·Filed 2004·Application pending·0 cites
- 1539US2019309054A1Non-polyaminated lcn2 as a biomarker for diagnosis and treatment of cardiometabolic diseasesUNIV HONG KONG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →